Loading
Latest filing published 02 Jul 2020 for American BIO Medica CORP, €12k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Chaim Davis discloses dealings in 2 companies, chiefly American BIO Medica Corp and LandBank Group Inc. We count 10 filings; the first trade dates from 12 March 2013 and the latest from 1 July 2020.
The open-market record is one-sided, with 3 purchases worth €116k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 7 share grants. 2020 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €38k.
The record was last updated on 2 July 2020 with a share grant (€12k) in American BIO Medica Corp. The last insider purchase was made public on 3 March 2020, 2,426 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations